Yolles Robert A. 4
4 · Winston Pharmaceuticals, Inc. · Filed Oct 1, 2009
Insider Transaction Report
Form 4
Yolles Robert A.
Director
Transactions
- Award
Common Stock Options
2009-09-25+30,000→ 30,000 totalExercise: $1.36Exp: 2019-09-25→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Such options vest in five equal annual installments, commencing 09/25/2010.
- [F2]Reported amount excludes: (i) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2003 and expiring on 09/09/2012, at an exercise price of $0.33; (ii) options to purchase 16,548 shares of the Company's common stock, initially exercisable on 09/09/2004 and expiring on 09/09/2013, at an exercise price of $0.33; (iii) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2005 and expiring on 09/09/2014, at an exercise price of $0.34; (iv) options to purchase 99,287 shares of the Company's common stock, initially exercisable on 02/18/2006 and expiring on 02/18/2015, at an exercise price of $0.34;
- [F3](v) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2006 and expiring on 09/09/2015, at an exercise price of $0.34; (vi) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2007 and expiring on 09/09/2016, at an exercise price of $0.34; and (vii) options to purchase 33,096 shares of the Company's common stock, initially exercisable on 09/09/2008 and expiring on 09/09/2017, at an exercise price of $0.34.